Hjem › Crohns sykdom › Texas › San Antonio
Kliniske studier for Crohns sykdom i San Antonio, TX
15 studier for Crohns sykdom søker deltakere på steder i og rundt San Antonio (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekruttererFase 2
- Southern Star Research Institute /ID# 280822, San Antonio
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RekruttererFase 3
- Southern Star Research Institute ( Site 0299), San Antonio
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RekruttererFase 3
- Southern Star Research Institute ( Site 5000), San Antonio
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
RekruttererFase 2
- Sun Research Institute /ID# 266723, San Antonio
- Southern Star Research Institute /ID# 278124, San Antonio
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 2
- Southern Star Research Institute, LLC, San Antonio
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 3
- Gastroenterology Research of America, LLC, San Antonio
- Southern Star Research Institute, LLC, San Antonio
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 2/3
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RekruttererFase 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 3
- Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 3
- Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
RekruttererFase 2
- Southern Star Research Institute, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
RekruttererFase 2
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RekruttererFase 4
- Gastroenterology Research of San Antonio, LLC, San Antonio
- Southern Star Research Institute, LLC., San Antonio
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
RekruttererFase 3
- Southern Star Research Institute, LLC, San Antonio
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
RekruttererFase 2
- Southern Star Research Institute, LLC, San Antonio
Crohns sykdom-studier i andre byer
- New York City, NY35 studier
- Boston, MA19 studier
- Miami, FL19 studier
- Cleveland, OH19 studier
- St. Louis, MO19 studier
- Tyler, TX17 studier
- Houston, TX17 studier
- Orlando, FL17 studier
- Atlanta, GA17 studier
- San Diego, CA15 studier
- Los Angeles, CA15 studier
- Colorado Springs, CO13 studier
Andre studier i San Antonio
- Ikke-småcellet lungekreft59 studier
- Brystkreft47 studier
- Kolorektal kreft46 studier
- Metastatisk kreft44 studier
- Kreft (alle typer)41 studier
- Fedme40 studier
- Type 2-diabetes37 studier
- Overvekt34 studier
- Eggstokkreft31 studier
- Pankreaskreft31 studier
- Prostatakreft28 studier
- Endometriekreft27 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.